Natus Medical, Inc. (BABY) Reports In-Line Q3 EPS; Guides Q4, FY11 EPS ,Revs
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q3 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $51.3 million versus the consensus estimate of $51.49 million.
Natus Medical, Inc. sees FY2011 EPS of $0.48, versus the consensus of $0.47. Natus Medical, Inc. sees FY2011 revenue of $234 million, versus the consensus of $233.41 million.
Natus Medical, Inc. sees Q4 2011 EPS of $0.15, versus the consensus of $0.15. Natus Medical, Inc. sees Q4 2011 revenue of $65 million, versus the consensus of $64.56 million.
Natus Medical, Inc. sees FY2011 EPS of $0.48, versus the consensus of $0.47. Natus Medical, Inc. sees FY2011 revenue of $234 million, versus the consensus of $233.41 million.
Natus Medical, Inc. sees Q4 2011 EPS of $0.15, versus the consensus of $0.15. Natus Medical, Inc. sees Q4 2011 revenue of $65 million, versus the consensus of $64.56 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
